Proteomic profiling and network biology of colorectal cancer liver metastasis

References

• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502. doi:10.1016/S0140-6736(13)61649-9
   PubMed Web of Science ®Google Scholar
• Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6(1):479–507. doi: 10.1146/annurev-pathol-011110-130235
   PubMed Web of Science ®Google Scholar
• Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350–1356. doi: 10.1038/nm.3967
   PubMed Web of Science ®Google Scholar
• Isella C, Brundu F, Bellomo SE, et al. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. Nat Commun. 2017;8(1):15107. doi: 10.1038/ncomms15107
   PubMedGoogle Scholar
• Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670–691. doi:10.1016/j.cell.2016.11.037
   PubMed Web of Science ®Google Scholar
• Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46. doi:10.1158/2159-8290.CD-21-1059
   PubMed Web of Science ®Google Scholar
• Ell B, Kang Y. Transcriptional control of cancer metastasis. Trends Cell Biol. 2013;23(12):603–611. doi:10.1016/j.tcb.2013.06.001
   PubMed Web of Science ®Google Scholar
• Casal JI, Bartolomé RA. RGD cadherins and α2β1 integrin in cancer metastasis: a dangerous liaison. Biochim Biophys Acta Rev Cancer. 2018;1869(2):321–332. doi:10.1016/j.bbcan.2018.04.005
   PubMed Web of Science ®Google Scholar
• Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21(4):217–238. doi:10.1038/s41568-020-00329-7
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Munro MJ, Wickremesekera SK, Peng L, et al. Cancer stem cells in colorectal cancer: a review. J Clin Pathol. 2018;71(2):110–116. doi:10.1136/jclinpath-2017-204739
   PubMed Web of Science ®Google Scholar
• Oskarsson T, Batlle E, Massague J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14(3):306–321. doi:10.1016/j.stem.2014.02.002
   PubMed Web of Science ®Google Scholar
• Peitzsch C, Tyutyunnykova A, Pantel K, et al. Cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol. 2017;44:10–24. doi:10.1016/j.semcancer.2017.02.011
   PubMed Web of Science ®Google Scholar
• Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14(3):275–291. doi:10.1016/j.stem.2014.02.006
   PubMed Web of Science ®Google Scholar
• Donnenberg VS, Donnenberg AD. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol. 2005;45(8):872–877. doi:10.1177/0091270005276905
   PubMed Web of Science ®Google Scholar
• Hsu CS, Tung CY, Yang CY, et al. Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620. PLoS One. 2013;8(4):e61133. doi:10.1371/journal.pone.0061133
   PubMed Web of Science ®Google Scholar
• Wong GYM, Diakos C, Hugh TJ, et al. Proteomic profiling and biomarker discovery in colorectal liver metastases. Int J Mol Sci. 2022;23(11):6091. doi: 10.3390/ijms23116091
   PubMed Web of Science ®Google Scholar
• de Wit M, Fijneman RJ, Verheul HM, et al. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. Clin Biochem. 2013;46(6):466–479. doi:10.1016/j.clinbiochem.2012.10.039
   PubMed Web of Science ®Google Scholar
• Li C, Sun YD, Yu GY, et al. Integrated omics of metastatic colorectal cancer. Cancer Cell. 2020;38(5):734–747 e739. doi: 10.1016/j.ccell.2020.08.002
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 2014;513(7518):382–387. doi: 10.1038/nature13438
   PubMed Web of Science ®Google Scholar
• Bartolome RA, Barderas R, Torres S, et al. Cadherin-17 interacts with alpha2beta1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis. Oncogene. 2014;33(13):1658–1669. doi: 10.1038/onc.2013.117
   PubMed Web of Science ®Google Scholar
• Dunham WH, Mullin M, Gingras AC. Affinity-purification coupled to mass spectrometry: basic principles and strategies. Proteomics. 2012;12(10):1576–1590. doi:10.1002/pmic.201100523
   PubMed Web of Science ®Google Scholar
• McIntyre RE, Buczacki SJ, Arends MJ, et al. Mouse models of colorectal cancer as preclinical models. BioEssays. 2015;37(8):909–920. doi:10.1002/bies.201500032
   PubMed Web of Science ®Google Scholar
• Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990;247(4940):322–324. doi:10.1126/science.2296722
   PubMed Web of Science ®Google Scholar
• Sakai E, Nakayama M, Oshima H, et al. Combined mutation of Apc, Kras, and Tgfbr2 effectively drives metastasis of intestinal cancer. Cancer Res. 2018;78(5):1334–1346. doi: 10.1158/0008-5472.CAN-17-3303
   PubMed Web of Science ®Google Scholar
• Jackstadt R, van Hooff SR, Leach JD, et al. Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis. Cancer Cell. 2019;36(3):319–336 e317. doi: 10.1016/j.ccell.2019.08.003
   PubMed Web of Science ®Google Scholar
• Barderas R, Villar-Vázquez R, Fernández-Aceñero MJ, et al. Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis. Sci Rep. 2013;3(1):2938. doi: 10.1038/srep02938
   PubMedGoogle Scholar
• Neufert C, Heichler C, Brabletz T, et al. Inducible mouse models of colon cancer for the analysis of sporadic and inflammation-driven tumor progression and lymph node metastasis. Nat Protoc. 2021;16(1):61–85. doi: 10.1038/s41596-020-00412-1
   PubMed Web of Science ®Google Scholar
• Torres S, Bartolome RA, Mendes M, et al. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res. 2013;19(21):6006–6019. doi: 10.1158/1078-0432.CCR-13-1130
   PubMed Web of Science ®Google Scholar
• Torres S, Garcia-Palmero I, Herrera M, et al. LOXL2 is highly expressed in cancer-associated fibroblasts and associates to poor colon cancer survival. Clin Cancer Res. 2015;21(21):4892–4902. doi: 10.1158/1078-0432.CCR-14-3096
   PubMed Web of Science ®Google Scholar
• Wong CC, Tse AP, Huang YP, et al. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 2014;60(5):1645–1658. doi: 10.1002/hep.27320
   PubMed Web of Science ®Google Scholar
• García-Palmero I, Torres S, Bartolomé RA, et al. Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI). Oncogene. 2016;35(40):5224–5236. doi: 10.1038/onc.2016.57
   PubMed Web of Science ®Google Scholar
• Bose S, Clevers H, Shen X. Promises and challenges of organoid-Guided Precision Medicine. Med. 2021;2(9):1011–1026. doi:10.1016/j.medj.2021.08.005
   PubMedGoogle Scholar
• Fumagalli A, Suijkerbuijk SJE, Begthel H, et al. A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression. Nat Protoc. 2018;13(2):235–247. doi: 10.1038/nprot.2017.137
   PubMed Web of Science ®Google Scholar
• Codrich M, Dalla E, Mio C, et al. Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN. J Exp Clin Cancer Res. 2021;40(1):198. doi: 10.1186/s13046-021-01986-8
   PubMed Web of Science ®Google Scholar
• O’Rourke KP, Loizou E, Livshits G, et al. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat Biotechnol. 2017;35(6):577–582. doi: 10.1038/nbt.3837
   PubMed Web of Science ®Google Scholar
• de Sousa EMF, Harnoss JM, Kljavin N, et al. Modeling colorectal cancer progression through orthotopic implantation of organoids. Methods Mol Biol. 2020;2171:331–346.
   PubMedGoogle Scholar
• Cristobal A, van den Toorn HWP, van de Wetering M, et al. Personalized Proteome profiles of healthy and tumor human colon organoids reveal both individual diversity and basic features of colorectal cancer. Cell Rep. 2017;18(1):263–274. doi:10.1016/j.celrep.2016.12.016
   PubMed Web of Science ®Google Scholar
• Dijkstra JJ, Neikes HK, Rezaeifard S, et al. Multiomics of colorectal cancer organoids reveals putative mediators of cancer progression resulting from SMAD4 inactivation. J Proteome Res. 2023;22(1):138–151. doi: 10.1021/acs.jproteome.2c00551
   PubMed Web of Science ®Google Scholar
• Lindeboom RG, van Voorthuijsen L, Oost KC, et al. Integrative multi-omics analysis of intestinal organoid differentiation. Mol Syst Biol. 2018;14(6):e8227. doi: 10.15252/msb.20188227
   PubMed Web of Science ®Google Scholar
• Medico E, Russo M, Picco G, et al. The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets. Nat Commun. 2015;6(1):7002. doi: 10.1038/ncomms8002
   PubMedGoogle Scholar
• Barderas R, Bartolome RA, Fernandez-Acenero MJ, et al. High expression of IL-13 receptor alpha2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res. 2012;72(11):2780–2790. doi:10.1158/0008-5472.CAN-11-4090
   PubMed Web of Science ®Google Scholar
• Luque-Garcia JL, Martinez-Torrecuadrada JL, Epifano C, et al. Differential protein expression on the cell surface of colorectal cancer cells is associated to tumor metastasis. Proteomics. 2010;10(5):940–952. doi:10.1002/pmic.200900441
   PubMed Web of Science ®Google Scholar
• Hegde P, Qi R, Gaspard R, et al. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res. 2001;61(21):7792–7797.
   PubMed Web of Science ®Google Scholar
• Tay PN, Tan P, Lan Y, et al. Palladin, an action-associated protein, is required for adherens junction formation and intercellular adhesion in HCT116 colorectal cancer cells. Int J Oncol. 2010;37(4):909–926. doi: 10.3892/ijo_00000742
   PubMed Web of Science ®Google Scholar
• Leibovitz A, Stinson JC, WB M, 3rd, CE M, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36(12): 4562–4569. 3rd.
   PubMed Web of Science ®Google Scholar
• Morikawa K, Walker SM, Nakajima M, et al. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 1988;48(23):6863–6871.
   PubMed Web of Science ®Google Scholar
• Berg KCG, Eide PW, Eilertsen IA, et al. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Mol Cancer. 2017;16(1):116. doi: 10.1186/s12943-017-0691-y
   PubMedGoogle Scholar
• Mendes M, Peláez-García A, López-Lucendo M, et al. Mapping the spatial Proteome of metastatic cells in colorectal cancer. Proteomics. 2017;17(19):1700094. doi: 10.1002/pmic.201700094
   Web of Science ®Google Scholar
• Dang Y, Zhang S, Wang Y, et al. State-of-the-art: exosomes in colorectal cancer. Curr Cancer Drug Targets. 2022;22(1):2–17. doi:10.2174/1568009621666211110094442
   PubMed Web of Science ®Google Scholar
• Solis-Fernandez G, Montero-Calle A, Sanchez-Martinez M, et al. Aryl-hydrocarbon receptor-interacting protein regulates tumorigenic and metastatic properties of colorectal cancer cells driving liver metastasis. Br J Cancer. 2022;126(11):1604–1615. doi: 10.1038/s41416-022-01762-1
   PubMed Web of Science ®Google Scholar
• Tan HT, Wu W, Ng YZ, et al. Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker. J Proteome Res. 2012;11(2):1433–1445. doi: 10.1021/pr2010956
   PubMed Web of Science ®Google Scholar
• Lei Y, Huang K, Gao C, et al. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol & Cell Proteomics. 2011;10(10):M110 005397. doi: 10.1074/mcp.M110.005397
   PubMed Web of Science ®Google Scholar
• van Huizen NA, Coebergh van den Braak RRJ, Doukas M, et al. Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue. J Biol Chem. 2019;294(1):281–289. doi:10.1074/jbc.RA118.005087
   PubMed Web of Science ®Google Scholar
• Yang Q, Bavi P, Wang JY, et al. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases. J Proteomics. 2017;168:53–65. doi:10.1016/j.jprot.2017.06.021
   PubMed Web of Science ®Google Scholar
• Bartolomé RA, Peláez-García A, Gomez I, et al. An RGD motif present in cadherin 17 induces integrin activation and tumor growth. J Biol Chem. 2014;289(50):34801–34814. doi: 10.1074/jbc.M114.600502
   PubMed Web of Science ®Google Scholar
• Bartolomé RA, Torres S, de Val S I, et al. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers. Oncotarget. 2017;8(1):215–227. doi: 10.18632/oncotarget.13832
   PubMedGoogle Scholar
• Casal JI, Bartolomé RA. Beyond N-Cadherin, relevance of cadherins 5, 6 and 17 in cancer progression and metastasis. Int J Mol Sci. 2019;20(13):3373. doi: 10.3390/ijms20133373
   PubMed Web of Science ®Google Scholar
• Bartolome RA, Robles J, Martin-Regalado A, et al. CDH6-activated αIIbβ3 crosstalks with α2β1 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers. Mol Oncol. 2021;15(7):1849–1865. doi: 10.1002/1878-0261.12947
   PubMed Web of Science ®Google Scholar
• Tian X, Han Z, Zhu Q, et al. Silencing of cadherin-17 enhances apoptosis and inhibits autophagy in colorectal cancer cells. Biomed Pharmacother. 2018;108:331–337. doi: 10.1016/j.biopha.2018.09.020
   PubMed Web of Science ®Google Scholar
• Ko S, Chu KM, Luk JM, et al. Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. Biochem Biophys Res Commun. 2004;319(2):562–568. doi: 10.1016/j.bbrc.2004.04.197
   PubMed Web of Science ®Google Scholar
• Tournier B, Aucagne R, Truntzer C, et al. Integrative clinical and DNA methylation analyses in a Population-based Cohort identifies CDH17 and LRP2 as risk recurrence factors in stage II colon cancer. Cancers (Basel). 2022;15(1):158. doi: 10.3390/cancers15010158
   PubMed Web of Science ®Google Scholar
• Lee CW, Lin SE, Tsai HI, et al. Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinoma. Oncol Lett. 2018;15(1):559–567. doi: 10.3892/ol.2017.7320
   PubMed Web of Science ®Google Scholar
• Bartolomé RA, Aizpurua C, Jaén M, et al. Monoclonal antibodies directed against cadherin RGD exhibit therapeutic activity against melanoma and colorectal cancer metastasis. Clin Cancer Res. 2018;24(2):433–444. doi: 10.1158/1078-0432.CCR-17-1444
   PubMed Web of Science ®Google Scholar
• Feng Z, He X, Zhang X, et al. Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nat Cancer. 2022;3(5):581–594. doi: 10.1038/s43018-022-00344-7
   PubMedGoogle Scholar
• Wong KK. Integrated transcriptomics and proteomics data analysis identifies CDH17 as a key cell surface target in colorectal cancer. Comput Biol Chem. 2023;105:107897. doi:10.1016/j.compbiolchem.2023.107897
   PubMed Web of Science ®Google Scholar
• Bialucha CU, Collins SD, Li X, et al. Discovery and optimization of HKT288, a cadherin-6-targeting ADC for the treatment of ovarian and renal cancers. Cancer Discov. 2017;7(9):1030–1045. doi: 10.1158/2159-8290.CD-16-1414
   PubMed Web of Science ®Google Scholar
• de Wit M, Jimenez CR, Carvalho B, et al. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut. 2012;61(6):855–864. doi: 10.1136/gutjnl-2011-300511
   PubMed Web of Science ®Google Scholar
• Schunter AJ, Yue X, Hummon AB. Phosphoproteomics of colon cancer metastasis: comparative mass spectrometric analysis of the isogenic primary and metastatic cell lines SW480 and SW620. Anal Bioanal Chem. 2017;409(7):1749–1763. doi:10.1007/s00216-016-0125-5
   PubMed Web of Science ®Google Scholar
• Nataraj NB, Marrocco I, Yarden Y. Roles for growth factors and mutations in metastatic dissemination. Biochem Soc Trans. 2021;49(3):1409–1423. doi:10.1042/BST20210048
   PubMed Web of Science ®Google Scholar
• Jaén M, Á M-R, Bartolomé RA, et al. Interleukin 13 receptor alpha 2 (IL13Rα2): expression, signaling pathways and therapeutic applications in cancer. Biochim Biophys Acta Rev Cancer. 2022;1877(5):188802. doi:10.1016/j.bbcan.2022.188802
   PubMed Web of Science ®Google Scholar
• Bartolome RA, Garcia-Palmero I, Torres S, et al. IL13 receptor alpha2 signaling requires a scaffold protein, FAM120A, to activate the FAK and PI3K pathways in colon cancer metastasis. Cancer Res. 2015;75(12):2434–2444. doi:10.1158/0008-5472.CAN-14-3650
   PubMed Web of Science ®Google Scholar
• Bartolome RA, Martin-Regalado A, Jaen M, et al. Protein tyrosine phosphatase-1B inhibition disrupts IL13Rα2-promoted invasion and metastasis in cancer cells. Cancers (Basel). 2020;12(2):500. doi: 10.3390/cancers12020500
   PubMed Web of Science ®Google Scholar
• Liu X, Brodeur SR, Gish G, et al. Regulation of c-src tyrosine kinase activity by the src SH2 domain. Oncogene. 1993;8(5):1119–1126.
   PubMed Web of Science ®Google Scholar
• Lupardus PJ, Birnbaum ME, Garcia KC. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure. 2010;18(3):332–342. doi:10.1016/j.str.2010.01.003
   PubMed Web of Science ®Google Scholar
• Bartolome RA, Jaen M, Casal JI. An IL13Ralpha2 peptide exhibits therapeutic activity against metastatic colorectal cancer. Br J Cancer. 2018;119(8):940–949. doi:10.1038/s41416-018-0259-7
   PubMed Web of Science ®Google Scholar
• Jaén M, Bartolomé RA, Aizpurua C, et al. Inhibition of liver metastasis in colorectal cancer by targeting IL-13/IL13Rα2 binding site with specific monoclonal antibodies. Cancers (Basel). 2021;13(7):1731. doi: 10.3390/cancers13071731
   PubMed Web of Science ®Google Scholar
• Krishnan N, Koveal D, Miller DH, et al. Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol. 2014;10(7):558–566. doi: 10.1038/nchembio.1528
   PubMed Web of Science ®Google Scholar
• Marquez-Ortiz RA, Contreras-Zarate MJ, Tesic V, et al. IL13Ralpha2 promotes proliferation and outgrowth of breast cancer brain metastases. Clin Cancer Res. 2021;27(22):6209–6221. doi: 10.1158/1078-0432.CCR-21-0361
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Joshi B, Nakajima A, et al. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Cancer Res. 2009;69(22):8678–8685. doi:10.1158/0008-5472.CAN-09-2100
   PubMed Web of Science ®Google Scholar
• Mende AL, Schulte JD, Okada H, et al. Current advances in immunotherapy for glioblastoma. Curr Oncol Rep. 2021;23(2):21. doi:10.1007/s11912-020-01007-5
   PubMed Web of Science ®Google Scholar
• Knudson KM, Hwang S, McCann MS, et al. Recent advances in IL-13Ralpha2-directed cancer immunotherapy. Front Immunol. 2022;13:878365. doi:10.3389/fimmu.2022.878365
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu L, Wang S, et al. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. J Cancer Res Clin Oncol. 2007;133(10):771–782. doi:10.1007/s00432-007-0222-0
   PubMed Web of Science ®Google Scholar
• Zhu L, Ren S, Daniels MJ, et al. Exogenous HMGB1 promotes the proliferation and metastasis of pancreatic cancer cells. Front Med. 2021;8:756988. doi: 10.3389/fmed.2021.756988
   Web of Science ®Google Scholar
• Barderas R, Mendes M, Torres S, et al. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion. Mol & Cell Proteomics. 2013;12(6):1602–1620. doi: 10.1074/mcp.M112.022848
   PubMed Web of Science ®Google Scholar
• Escudero-Paniagua B, Bartolomé RA, Rodríguez S, et al. PAUF/ZG16B promotes colorectal cancer progression through alterations of the mitotic functions and the Wnt/β-catenin pathway. Carcinogenesis. 2020;41(2):203–213. doi: 10.1093/carcin/bgz093
   PubMed Web of Science ®Google Scholar
• Youn SE, Jiang F, Won HY, et al. PAUF induces migration of human pancreatic cancer cells exclusively via the TLR4/MyD88/NF-κB signaling pathway. Int J Mol Sci. 2022;23(19):11414. doi: 10.3390/ijms231911414
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee Y, Kim NY, et al. Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability. Oncogene. 2013;32(31):3638–3647. doi: 10.1038/onc.2012.366
   PubMed Web of Science ®Google Scholar
• Gao H, Chakraborty G, Lee-Lim AP, et al. The BMP inhibitor coco reactivates breast cancer cells at lung metastatic sites. Cell. 2012;150(4):764–779. doi: 10.1016/j.cell.2012.06.035
   PubMed Web of Science ®Google Scholar
• Bartolomé RA, Pintado-Berninches L, Jaén M, et al. SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166. Oncogene. 2020;39(38):6085–6098. doi:10.1038/s41388-020-01419-4
   PubMed Web of Science ®Google Scholar
• Yang Y, Sanders AJ, Dou QP, et al. The clinical and theranostic values of activated leukocyte cell adhesion molecule (ALCAM)/CD166 in human solid cancers. Cancers (Basel). 2021;13(20):5187. doi: 10.3390/cancers13205187
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi: 10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Choi DS, Choi DY, Hong BS, et al. Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J Extracell Vesicles. 2012;1(1). doi: 10.3402/jev.v1i0.18704
   PubMedGoogle Scholar
• Ji H, Greening DW, Barnes TW, et al. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics. 2013;13(10–11):1672–1686. doi: 10.1002/pmic.201200562
   PubMed Web of Science ®Google Scholar
• Suwakulsiri W, Rai A, Xu R, et al. Proteomic profiling reveals key cancer progression modulators in shed microvesicles released from isogenic human primary and metastatic colorectal cancer cell lines. Biochim Biophys Acta Proteins Proteom. 2019;1867(12):140171. doi:10.1016/j.bbapap.2018.11.008
   PubMed Web of Science ®Google Scholar
• Robles J, Pintado-Berninches L, Boukich I, et al. A prognostic six-gene expression risk-score derived from proteomic profiling of the metastatic colorectal cancer secretome. J Pathol Clin Res. 2022;8(6):495–508. doi: 10.1002/cjp2.294
   PubMedGoogle Scholar
• Miyahara Y, Takano S, Sogawa K, et al. Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. Cancer Sci. 2022;113(8):2548–2559. doi: 10.1111/cas.15444
   PubMed Web of Science ®Google Scholar
• Hatsuzawa Y, Yamaguchi K, Takanashi T, et al. CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. Pancreatology. 2020;20(3):493–500. doi: 10.1016/j.pan.2020.01.013
   PubMed Web of Science ®Google Scholar
• Huang Y, Chang A, Zhou W, et al. IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma. Clin Exp Med. 2020;20(4):515–525. doi:10.1007/s10238-020-00642-3
   PubMed Web of Science ®Google Scholar
• Cruz PM, Mo H, McConathy WJ, et al. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 2013;4:119. doi:10.3389/fphar.2013.00119
   PubMed Web of Science ®Google Scholar
• Ding C, Chan DW, Liu W, et al. Proteome-wide profiling of activated transcription factors with a concatenated tandem array of transcription factor response elements. Proc Natl Acad Sci U S A. 2013;110(17):6771–6776. doi: 10.1073/pnas.1217657110
   PubMed Web of Science ®Google Scholar
• Torres S, Garcia-Palmero I, Marin-Vicente C, et al. Proteomic characterization of transcription and splicing factors associated with a metastatic phenotype in colorectal cancer. J Proteome Res. 2018;17(1):252–264. doi: 10.1021/acs.jproteome.7b00548
   PubMed Web of Science ®Google Scholar
• Okumura N, Yoshida H, Kitagishi Y, et al. Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer. Biochem Biophys Res Commun. 2011;413(3):395–399. doi:10.1016/j.bbrc.2011.08.098
   PubMed Web of Science ®Google Scholar
• Sen S, Langiewicz M, Jumaa H, et al. Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice. Hepatology. 2015;61(1):171–183. doi:10.1002/hep.27380
   PubMed Web of Science ®Google Scholar
• Liu J, Huang B, Xiao Y, et al. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia. Onkologie. 2012;35(6):335–340. doi: 10.1159/000338941
   PubMedGoogle Scholar
• Jansson EA, Are A, Greicius G, et al. The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells. Proc Natl Acad Sci U S A. 2005;102(5):1460–1465. doi: 10.1073/pnas.0405928102
   PubMed Web of Science ®Google Scholar
• Zanocco-Marani T, Vignudelli T, Parenti S, et al. TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation. Exp Cell Res. 2009;315(11):1798–1808. doi: 10.1016/j.yexcr.2009.03.018
   PubMed Web of Science ®Google Scholar
• Fang M, Ou J, Hutchinson L, et al. The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG island methylator phenotype. Mol Cell. 2014;55(6):904–915. doi:10.1016/j.molcel.2014.08.010
   PubMed Web of Science ®Google Scholar
• Kasuya K, Nagakawa Y, Hosokawa Y, et al. RhoA activity increases due to hypermethylation of ARHGAP28 in a highly liver-metastatic colon cancer cell line. Biomed Rep. 2016;4(3):335–339. doi: 10.3892/br.2016.582
   PubMedGoogle Scholar
• Chen DL, Wang ZQ, Zeng ZL, et al. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression. Hepatology. 2014;60(2):598–609. doi: 10.1002/hep.27118
   PubMed Web of Science ®Google Scholar
• Chen HY, Lin YM, Chung HC, et al. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2012;72(14):3631–3641. doi: 10.1158/0008-5472.CAN-12-0667
   PubMed Web of Science ®Google Scholar
• Gao J, Li N, Dong Y, et al. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene. 2014;34(31):4142–4152. doi: 10.1038/onc.2014.348
   PubMed Web of Science ®Google Scholar
• Geng L, Chaudhuri A, Talmon G, et al. MicroRNA-192 suppresses liver metastasis of colon cancer. Oncogene. 2014;33(46):5332–5340. doi: 10.1038/onc.2013.478
   PubMed Web of Science ®Google Scholar
• Hur K, Toiyama Y, Schetter AJ, et al. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. J Natl Cancer Inst. 2015;107(3). doi: 10.1093/jnci/dju492
   PubMedGoogle Scholar
• Hur K, Toiyama Y, Takahashi M, et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. 2013;62(9):1315–1326. doi: 10.1136/gutjnl-2011-301846
   PubMed Web of Science ®Google Scholar
• Jahid S, Sun J, Edwards RA, et al. miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov. 2012;2(6):540–553. doi: 10.1158/2159-8290.CD-11-0267
   PubMed Web of Science ®Google Scholar
• Okamoto K, Ishiguro T, Midorikawa Y, et al. miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver. EMBO J. 2012;31(7):1752–1763. doi: 10.1038/emboj.2012.25
   PubMed Web of Science ®Google Scholar
• Loo JM, Scherl A, Nguyen A, et al. Extracellular metabolic energetics can promote cancer progression. Cell. 2015;160(3):393–406. doi: 10.1016/j.cell.2014.12.018
   PubMed Web of Science ®Google Scholar
• Torres S, Garcia-Palmero I, Bartolome RA, et al. Combined miRNA profiling and proteomics demonstrates that different miRnas target a common set of proteins to promote colorectal cancer metastasis. J Pathol. 2017;242(1):39–51. doi: 10.1002/path.4874
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang W, Yang AG, et al. The microRNA-424/503 cluster: a master regulator of tumorigenesis and tumor progression with paradoxical roles in cancer. Cancer Lett. 2020;494:58–72. doi:10.1016/j.canlet.2020.08.027
   PubMed Web of Science ®Google Scholar
• Vasaikar S, Huang C, Wang X, et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell. 2019;177(4):1035–1049 e1019. doi: 10.1016/j.cell.2019.03.030
   PubMed Web of Science ®Google Scholar